Adagene Inc. ADAG

Full chart Compare
Set alert

Price alert · ADAG

All alert types
2.35 USD +0.06 (+2.62%)

At closeNov 3, 2026, 4:00 PM EST

2.35 0.00 0.00%

After hours · Nov 3, 4:00 PM ET

2.26 Day range 2.54
1.30 52-week range 4.85
YTD
+24.34%
1 year
+31.28%

Analyst view

Price target (mean) 8.03 +241.6% upside
Target (low)
3.50
Target (mean)
8.03
Target (high)
18.81
Ratings (0m) 4 3 buy · 1 hold · 0 sell
  • Strong buy2
  • Buy1
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 4
  • 1 month ago 4
  • 2 months ago 4

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

ADAG analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current year-0.58-0.72 – -0.44-0.21-176.2%12.33M-31.9%2
Next year-0.775-1.04 – -0.51-0.58-33.6%12.67M+2.7%2

Upgrades and downgrades

The latest rating changes

ADAG analyst upgrades and downgrades
DateFirmActionFromTo
Sep 18, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jul 22, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jun 28, 2024HC Wainwright & Co.ReiteratedBuyBuy
Oct 4, 2023HC Wainwright & Co.ReiteratedBuyBuy
Sep 1, 2023HC Wainwright & Co.ReiteratedBuyBuy
Apr 21, 2023HC Wainwright & Co.Reiterated—Buy
Mar 29, 2023HC Wainwright & Co.Reiterated—Buy
Mar 21, 2023HC Wainwright & Co.Reiterated—Buy
Jan 24, 2023Morgan StanleyMaintained—Overweight
Dec 7, 2022HC Wainwright & Co.Initiated—Buy
Sep 9, 2022Morgan StanleyMaintained—Overweight
Feb 1, 2022Morgan StanleyMaintained—Overweight
Jan 6, 2022Morgan StanleyMaintained—Overweight
Jul 16, 2021Morgan StanleyMaintained—Overweight
Jun 25, 2021China RenaissanceInitiated—Buy
Mar 8, 2021JefferiesInitiated—Buy
Mar 8, 2021Morgan StanleyInitiated—Overweight